{"id":13193,"date":"2024-03-22T08:37:56","date_gmt":"2024-03-22T11:37:56","guid":{"rendered":"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/"},"modified":"2024-03-22T08:37:56","modified_gmt":"2024-03-22T11:37:56","slug":"computer-based-de-novo-design-of-drug-like-molecules-nature","status":"publish","type":"post","link":"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/","title":{"rendered":"Computer-based de novo design of drug-like molecules – Nature"},"content":{"rendered":"

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
Advertisement
Nature Reviews Drug Discovery<\/i><\/a> volume<\/span>\u00a04<\/b>,\u00a0pages <\/span>649\u2013663 (2005<\/span>)Cite this article<\/a>
11k Accesses<\/span>
614 Citations<\/span>
21 Altmetric<\/span>
Metrics details<\/span><\/a>
Molecular de novo<\/i> design, which involves incremental construction of a ligand model within a model of the receptor or enzyme active site, produces novel molecular structures with desired pharmacological properties from scratch.
De novo<\/i> molecule-design software is confronted with a virtually infinite search space. As such a large space prohibits exhaustive searching, navigation in the de novo<\/i> design process relies on the principle of local optimization.
Basically, three questions have to be addressed by a de novo<\/i> design program: how to assemble the candidate compounds; how to evaluate their potential quality; and how to sample the search space effectively.
This review gives an overview of computer-based molecular de novo<\/i> design methods on a conceptual level, considering these three questions, and focusing on the design of small, drug-like molecules. Successful examples of de novo<\/i> design in the hit- and lead-finding stages of the drug discovery process are used to show that de novo<\/i> design provides a method for lead identification.
De novo<\/i> design can therefore be regarded as a complement to other virtual techniques, such as database searching, and non-virtual techniques such as high-throughput screening. We also accentuate strengths and weaknesses of current de novo<\/i> design approaches.
Ever since the first automated de novo<\/i> design techniques were conceived only 15 years ago, the computer-based design of hit and lead structure candidates has emerged as a complementary approach to high-throughput screening. Although many challenges remain, de novo<\/i> design supports drug discovery projects by generating novel pharmaceutically active agents with desired properties in a cost- and time-efficient manner. In this review, we outline the various design concepts and highlight current developments in computer-based de novo<\/i> design.
This is a preview of subscription content, access via your institution<\/a><\/p>\n

Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue<\/p>\n

Rent or buy this article
Prices vary by article type
from<\/span>$1.95
to<\/span>$39.95<\/p>\n

Prices may be subject to local taxes which are calculated during checkout
John Jumper, Richard Evans, \u2026 Demis Hassabis
Yuanyuan Jiang, Guo Zhang, \u2026 Shengyong Yang
Gabriele Corso, Hannes Stark, \u2026 Regina Barzilay
1fkf<\/a>
Dobson, C. M. Chemical space and biology. Nature<\/i> 432<\/b>, 824\u2013828 (2004).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Lipinski, C. & Hopkins, A. Navigating chemical space for biology and medicine. Nature<\/i> 432<\/b>, 855\u2013861 (2004).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Schneider, G. Trends in virtual combinatorial library design. Curr. Med. Chem.<\/i> 9<\/b>, 2095\u20132101 (2002).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Richardson, J. S. & Richardson, D. C. The de novo<\/i> design of protein structures. Trends Biochem. Sci.<\/i> 14<\/b>, 304\u2013309 (1989).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Richardson, J. S. et al. Looking at proteins: representations, folding, packing, and design. Biophys. J.<\/i> 63<\/b>, 1185\u20131209 (1992).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 PubMed Central<\/a>\u00a0 Google Scholar<\/a>\u00a0
Moon, J. B. & Howe, W. J. Computer design of bioactive molecules: a method for receptor-based de novo<\/i> ligand design. Proteins<\/i> 11<\/b>, 314\u2013328 (1991).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Schneider, G. & Wrede, P. The rational design of amino acid sequences by artificial neural networks and simulated molecular evolution: de novo<\/i> design of an idealized leader peptidase cleavage site. Biophys. J.<\/i> 66<\/b>, 335\u2013344 (1994).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 PubMed Central<\/a>\u00a0 Google Scholar<\/a>\u00a0
Schneider, G. et al. Peptide design by artificial neural networks and computer-based evolutionary search. Proc. Natl Acad. Sci. USA<\/i> 95<\/b>, 12179\u201312184 (1998).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 PubMed Central<\/a>\u00a0 Google Scholar<\/a>\u00a0
Venkatasubramanian, V., Chan, K. & Caruthers, J. M. Computer-aided molecular design using genetic algorithms. Computers Chem. Eng.<\/i> 18<\/b>, 833\u2013844 (1994).
Article<\/a>\u00a0 CAS<\/a>\u00a0 Google Scholar<\/a>\u00a0
Venkatasubramanian, V., Sundaram, A., Chan, K. & Caruthers, J. M. in Genetic Algorithms in Molecular Modelling<\/i> (ed. Devillers, J.) 271\u2013302 (Academic, London, 1996).
Book<\/a>\u00a0 Google Scholar<\/a>\u00a0
Sundaram, A. & Venkatasubramanian, V. Parametric sensitivity and search-space characterization studies of genetic algorithms for computer-aided polymer design. J. Chem. Inf. Comput. Sci.<\/i> 38<\/b>, 1177\u20131191 (1998).
Article<\/a>\u00a0 CAS<\/a>\u00a0 Google Scholar<\/a>\u00a0
Danziger, D. J. & Dean, P. M. Automated site-directed drug design: a general algorithm for knowledge acquisition about hydrogen-bonding regions at protein surfaces. Proc R Soc Lond B Biol Sci<\/i> B 236<\/b>, 101\u2013113 (1989). First work about interaction site derivation from a receptor structure tailored for the use in automated <\/b> de novo<\/i><\/b> design.<\/b>
PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
B\u00f6hm, H. -J. The computer program LUDI: a new simple method for the de-novo design of enzyme inhibitors. J. Comput. Aided Mol. Des.<\/i> 6<\/b>, 61\u201378 (1992).
Article<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
B\u00f6hm, H. -J. LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads. J. Comput. Aided Mol. Des.<\/i> 6<\/b>, 593\u2013606 (1992).
Article<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Clark, D. E. et al. PRO LIGAND: an approach to de novo<\/i> molecular design. 1. Application to the design of organic molecules. J. Comput. Aided Mol. Des.<\/i> 9<\/b>, 13\u201332 (1995). A comprehensive approach that adopts a lot of earlier ideas and provides new concepts.<\/b>
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Murray, C. W. et al. PRO_SELECT: combining structure-based drug design and combinatorial chemistry for rapid lead discovery. 1. Technology. J. Comp. Aided Mol. Des.<\/i> 11<\/b>, 193\u2013207 (1997).
Article<\/a>\u00a0 CAS<\/a>\u00a0 Google Scholar<\/a>\u00a0
Gillett, V. J., Myatt, G., Zsoldos, Z. & Johnson, A. P. SPROUT, HIPPO and CAESA: tools for de novo<\/i> structure generation and estimation of synthetic accessibility. Perspect. Drug Discov. Des.<\/i> 3<\/b>, 34\u201350 (1995).
Article<\/a>\u00a0 Google Scholar<\/a>\u00a0
Rotstein, S. H. & Murcko, M. A. GroupBuild: a fragment-based method for de novo<\/i> drug design. J. Med. Chem.<\/i> 36<\/b>, 1700\u20131710 (1993).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Goodford, P. J. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. Med. Chem.<\/i> 28<\/b>, 849\u2013857 (1985).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Nishibata, Y. & Itai, A. Automatic creation of dug candidate structures based on receptor structure. Starting point for artificial lead generation. Tetrahedron<\/i> 47<\/b>, 8985\u20138990 (1991).
Article<\/a>\u00a0 CAS<\/a>\u00a0 Google Scholar<\/a>\u00a0
Bohacek, R. S. & McMartin, C. Multiple highly diverse structures complementary to enzyme binding sites: results of extensive application of a de novo<\/i> design method incorporating combinatorial growth. J. Am. Chem. Soc.<\/i> 116<\/b>, 5560\u20135571 (1994).
Article<\/a>\u00a0 CAS<\/a>\u00a0 Google Scholar<\/a>\u00a0
Glen, R. C. & Payne, A. W. R. A genetic algorithm for the automated generation of molecules within constraints. J. Comput. Aided. Mol. Des.<\/i> 9<\/b>, 181\u2013202 (1995).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Luo, Z., Wang, R. & Lai, L. RASSE: a new method for structure-based drug design. J. Chem. Inf. Comput. Sci.<\/i> 36<\/b>, 1187\u20131194 (1996).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Wang, R., Gao, Y. & Lai, L. LigBuilder: a multi-purpose program for structure-based drug design. J. Mol. Model.<\/i> 6<\/b>, 498\u2013516 (2000).
Article<\/a>\u00a0 CAS<\/a>\u00a0 Google Scholar<\/a>\u00a0
Eisen, M. B., Wiley, D. C., Karplus, M. & Hubbard, R. E. HOOK: a program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macromolecule binding site. Proteins<\/i> 19<\/b>, 199\u2013221 (1994).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Miranker, A. & Karplus, M. An automated method for dynamic ligand design. Proteins<\/i> 23<\/b>, 472\u2013490 (1995).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Miranker, A. & Karplus, M. Functionality maps of binding sites: a multiple copy simultaneous search method. Proteins<\/i> 11<\/b>, 29\u201334 (1991).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Lewis, R. A. et al. Automated site-directed drug design using molecular lattices. J. Mol. Graphics<\/i> 10<\/b>, 66\u201378 (1992).
Article<\/a>\u00a0 CAS<\/a>\u00a0 Google Scholar<\/a>\u00a0
Roe, D. C. & Kuntz, I. D. BUILDER v.2: improving the chemistry of a de novo<\/i> design strategy. J. Comput. Aided Mol. Des.<\/i> 9<\/b>, 269\u2013282 (1995).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Tschinke, V. & Cohen, N. C. The NEWLEAD program: a new method for the design of candidate structures from pharmacophoric hypothesis. J. Med. Chem.<\/i> 36<\/b>, 3863\u20133870 (1993).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Lewis, R. A. & Dean, P. M. Automated site-directed drug design: the formation of molecular templates in primary structure generation. Proc R Soc Lond B Biol Sci <\/i> 236<\/b>, 141\u2013162 (1989).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Gillett, V. A., Johnson, A. P., Mata, P. & Sike, S. Automated structure design in 3D. Tetrahedron Comput. Method.<\/i> 3<\/b>, 681\u2013696 (1990).
Article<\/a>\u00a0 Google Scholar<\/a>\u00a0
Lewis, R. A. Automated site-directed drug design: approaches to the formation of 3D molecular graphs. J. Comput. Aided Mol. Des.<\/i> 4<\/b>, 205\u2013210 (1990).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Rotstein, S. H. & Murcko, M. A. GenStar: a method for de novo<\/i> drug design. J. Comput. Aided. Mol. Des.<\/i> 7<\/b>, 23\u201343 (1993).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Pearlman, D. A. & Murcko, M. A. CONCERTS: dynamic connection of fragments as an approach to de novo<\/i> ligand design. J. Med. Chem.<\/i> 39<\/b>, 1651\u20131663 (1996). Introduces the concept of consensus molecular dynamics as a method for structure sampling to <\/b> de novo<\/i><\/b> design.<\/b>
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Liu, H., Duan, Z., Luo, Q. & Shi, Y. Structure-based ligand design by dynamically assembling molecular building blocks at binding site. Proteins<\/i> 36<\/b>, 462\u2013470 (1999).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Zhu, J., Yu, H., Fan, H. Liu, H. & Shi, Y. Design of selective inhibitors of cyclooxygenase-2 dynamic assembly of molecular building blocks. J. Comput. Aided Mol. Des.<\/i> 15<\/b>, 447\u2013463 (2001).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Zhu, J., Fan, H., Liu, H. & Shi, Y. Structure-based ligand design for flexible proteins: application of new F-DycoBlock. J. Comput. Aided Mol. Des.<\/i> 15<\/b>, 979\u2013996 (2001).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Pearlman, D. A. & Murcko, M. A. CONCEPTS: new dynamic algorithm for de novo<\/i> design suggestion. J. Comput. Chem.<\/i> 14<\/b>, 1184\u20131193 (1993).
Article<\/a>\u00a0 CAS<\/a>\u00a0 Google Scholar<\/a>\u00a0
Eldridge, M. D., Murray, C. W., Auton, T. R., Paolini, G. V. & Mee, R. P. Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. J. Comput. Aided Mol. Des.<\/i> 11<\/b>, 425\u2013445 (1997).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
DeWitte, R. S. & Shakhnovich, E. I. SMoG de novo<\/i> design method based on simple, fast, and accurate free energy estimates. 1. Methodology and supporting evidence. J. Am. Chem. Soc.<\/i> 118<\/b>, 11733\u201311744 (1996).
Article<\/a>\u00a0 CAS<\/a>\u00a0 Google Scholar<\/a>\u00a0
Ishchenko, A. V. & Shakhnovich, E. I. SMall Molecule Growth 2001 (SMoG2001): an improved knowledge-based scoring function for protein\u2013ligand interactions. J. Med. Chem.<\/i> 45<\/b>, 2770\u20132780 (2002).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Wise, A., Gearing, K. & Rees, S. Target validation of G-protein coupled receptors. Drug Discov. Today<\/i> 7<\/b>, 235\u2013246 (2002).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Waszkowycz, B. et al. PRO LIGAND: an approach to de novo<\/i> molecular design. 2. design of novel molecules from molecular field analysis (MFA) models and pharmacophores. J. Med. Chem.<\/i> 37<\/b>, 3994\u20134002 (1994).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Nachbar, R. B. Molecular evolution: automated manipulation of hierarchical chemical topology and its application to average molecular structures. Genet. Programming Evolvable Machines<\/i> 1<\/b>, 57\u201394 (2000). Development of genetic operators for graph-based structure sampling and detailed description of the problems that have to be solved.<\/b>
Article<\/a>\u00a0 Google Scholar<\/a>\u00a0
Pellegrini, E. & Field, M. J. Development and testing of a de novo<\/i> drug-design algorithm. J. Comp. Aided Mol. Des.<\/i> 17<\/b>, 621\u2013641 (2003).
Article<\/a>\u00a0 CAS<\/a>\u00a0 Google Scholar<\/a>\u00a0
Douguet, D., Thoreau, E. & Grassy, G. A genetic algorithm for the automated generation of small organic molecules: drug design using an evolutionary algorithm. J. Comput. Aided Mol. Des.<\/i> 14<\/b>, 449\u2013466 (2000).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Schneider, G., Lee, M. -L., Stahl, M. & Schneider, P. De novo<\/i> design of molecular architectures by evolutionary assembly of drug-derived building blocks. J. Comput. Aided Mol. Des.<\/i> 14<\/b>, 487\u2013494 (2000).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Globus, A., Lawton, J. & Wipke, W. T. Automatic Molecular design using evolutionary algorithms. Nanotechnology<\/i> 10<\/b>, 290\u2013299 (1999).
Article<\/a>\u00a0 Google Scholar<\/a>\u00a0
Brown, N., McKay, B., Gilardoni, F. & Gasteiger, J. A graph-based genetic algorithm and its application to the multiobjective evolution of median molecules. J. Chem. Inf. Comput. Sci.<\/i> 44<\/b>, 1079\u20131087 (2004).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Lipinski, C. et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug. Deliv. Rev.<\/i> 23<\/b>, 3\u201325 (1997).
Article<\/a>\u00a0 CAS<\/a>\u00a0 Google Scholar<\/a>\u00a0
Teague, S. J. et al. The design of leadlike combinatorial libraries. Angew. Chem. Int. Ed. Engl.<\/i> 38<\/b>, 3743\u20133747 (1999).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Aronov, A. M. Predictive in silico<\/i> modeling for hERG channel blockers. Drug Discov. Today<\/i> 10<\/b>, 149\u2013155 (2005).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Lewell, X. O., Budd, D. B., Watson, S. P. & Hann, M. M. RECAP \u2013 Retrosynthetic Combinatorial Analysis Procedure: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry. J. Chem. Inf. Comput. Sci.<\/i> 38<\/b>, 511\u2013522 (1998).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Vinkers, H. M. et al. SYNOPSIS: SYNthesize and OPtimize System in Silico. J. Med. Chem.<\/i> 46<\/b>, 2765\u20132773 (2003).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Honma, T. et al. Structure-based generation of a new class of potent Cdk4 inhibitors: new de novo<\/i> design strategy and library design. J. Med. Chem.<\/i> 44<\/b>, 4615\u20134627 (2001).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Gillett, V., Johnson, P., Mata, P., Sike, S. & Williams, P. SPROUT: a program for structure generation. J. Comput. Aided Mol. Des.<\/i> 7<\/b>, 127\u2013153 (1993).
Article<\/a>\u00a0 Google Scholar<\/a>\u00a0
Gillet, V. et al. P. SPROUT: recent developments in the de novo<\/i> design of molecules. J. Chem. Inf. Comput. Sci.<\/i> 34<\/b>, 207\u2013217 (1994).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Mata, P. et al. SPROUT: 3D structure generation using templates. J. Chem. Inf. Comput. Sci.<\/i> 35<\/b>, 479\u2013493 (1995).
Article<\/a>\u00a0 CAS<\/a>\u00a0 Google Scholar<\/a>\u00a0
Ho, C. M. W. & Marshall, G. R. SPLICE: a program to assemble partial query solutions from three-dimensional database searches into novel ligands. J. Comput. Aided Mol. Des.<\/i> 7<\/b>, 623\u2013647 (1993).
Article<\/a>\u00a0 CAS<\/a>\u00a0 Google Scholar<\/a>\u00a0
Gelhaar, D. K. et al. De novo<\/i> design of enzyme inhibitors by monte carlo ligand generation. J. Med. Chem.<\/i> 38<\/b>, 466\u2013472 (1995).
Article<\/a>\u00a0 Google Scholar<\/a>\u00a0
Pierce, A. C., Rao, G. & Bemis, G. W. BREED: generating novel inhibitors through hybridization of known ligands. application to CDK2, P38, and HIV protease. J. Med. Chem.<\/i> 47<\/b>, 2768\u20132775 (2004).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Todorov, N. P. & Dean, P. M. Evaluation of a method for controlling molecular scaffold diversity in de novo<\/i> ligand design. J. Comput. Aided. Mol. Des.<\/i> 11<\/b>, 175\u2013192 (1997).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Todorov, N. P. & Dean, P. M. A branch-and-bound method for optimal atom-type assignment in de novo<\/i> ligand design. J. Comput. Aided. Mol. Des.<\/i> 12<\/b>, 335\u2013350 (1998).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Darwin, C. On the Origin of Species (Facsimile of the First Edition)<\/i> (Harvard Univ. Press, Cambridge, Massachusetts, 1859\/1975).
 Google Scholar<\/a>\u00a0
Weininger, D. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J. Chem. Inf. Comput. Sci.<\/i> 28<\/b>, 31\u201336 (1988).
Article<\/a>\u00a0 CAS<\/a>\u00a0 Google Scholar<\/a>\u00a0
Pegg, S. C. -H., Haresco, J. J. & Kuntz, I. D. A genetic algorithm for structure-based de novo<\/i> design. J. Comput. Aided Mol. Des.<\/i> 15<\/b>, 911\u2013933 (2001).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Schneider, G. & B\u00f6hm, H. -J. Virtual screening and fast automated docking methods. Drug Discov. Today<\/i> 7<\/b>, 64\u201370 (2002).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Hou, T. & Xu, X. Recent development and application of virtual screening in drug discovery: an overview. Curr. Pharm. Des.<\/i> 10<\/b>, 1011\u20131033 (2004).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Honma, T. Recent advances in de novo<\/i> design strategy for practical lead identification. Med. Res. Rev.<\/i> 23<\/b>, 606\u2013632 (2003).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Ji, H. et al. Structure-based de novo<\/i> design, synthesis, and biological evaluation of non-azole inhibitors specific for lanosterol 14\u03b1-demethylase of fungi. J. Med. Chem.<\/i> 46<\/b>, 474\u2013485 (2003).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Perola, E., Walters, W. P. & Charifson, P. S. A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance. Proteins<\/i> 56<\/b>, 235\u2013249 (2004).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Schuffenhauer, A. et al. Molecular diversity management strategies for building and enhancement of diverse and focused lead discovery compound screening collections. Comb. Chem. High Throughput Screen.<\/i> 7<\/b>, 771\u2013781 (2004).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Honma, T. et al. A novel approach for the development of selective Cdk4 inhibitors: library design based on locations of Cdk4 specific amino acid residues. J. Med. Chem.<\/i> 44<\/b>, 4628\u20134640 (2001).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Rogers-Evans, M., Alanine, A. I., Bleicher, K. H., Kube, D. & Schneider, G. Identification of novel cannabinoid receptor ligands via evolutionary de novo<\/i> design and rapid parallel synthesis. QSAR Comb. Sci.<\/i> 23<\/b>, 426\u2013430 (2004).
Article<\/a>\u00a0 CAS<\/a>\u00a0 Google Scholar<\/a>\u00a0
B\u00f6hm, H. -J., Banner, D. W. & Weber, L. Combinatorial docking and combinatorial chemistry: design of potent non-peptide thrombin inhibitors. J. Comput. Aided Mol. Des.<\/i> 13<\/b>, 51\u201356 (1999).
Article<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Obst, U., Banner, D. W., Weber, L. & Diederich, F. Molecular recognition at the thrombin active site: structure-based design and synthesis of potent and selective thrombin inhibitors and the X-ray crystal structures of two thrombin-inhibitor complexes. Chem. Biol.<\/i> 4<\/b>, 287\u2013295 (1997).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Olsen, J. A. et al. A fluorine scan of thrombin inhibitors to map the fluorophilicity\/fluorophobicity of an enzyme active site: evidence for C\u2013F…C=O interactions. Angew. Chem. Int. Ed. Eng.<\/i> 42<\/b>, 2507\u20132511 (2003).
Article<\/a>\u00a0 CAS<\/a>\u00a0 Google Scholar<\/a>\u00a0
Gribbon, P. & Sewing A. High-throughput drug discovery: what can we expect from HTS? Drug Discov. Today<\/i> 10<\/b>, 17\u201322 (2005).
Article<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Anderson, A. C. & Wright, D. L. The design and docking of virtual compound libraries to structures of drug targets. Curr. Comp. Aided Drug Des.<\/i> 1<\/b>, 103\u2013127 (2005). An excellent overview of current developments in molecular docking and scoring and its relation to <\/b> de novo<\/i><\/b> design.<\/b>
Article<\/a>\u00a0 CAS<\/a>\u00a0 Google Scholar<\/a>\u00a0
Doweyko, A. M. 3D-QSAR illusions. J. Comp. Aided Mol. Des.<\/i> 18<\/b>, 587\u2013596 (2004).
Article<\/a>\u00a0 CAS<\/a>\u00a0 Google Scholar<\/a>\u00a0
Bemis, G. W. & Murcko, M. A. The properties of known drugs. 1. Molecular frameworks. J. Med. Chem.<\/i> 39<\/b>, 2887\u20132893 (1996).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
M\u00fcller, G. in Chemogenomics in Drug Discovery<\/i> (eds Kubinyi, H. & M\u00fcller, G.) 7\u201341 (Wiley-VCH, Weinheim, 2004).
 Google Scholar<\/a>\u00a0
Jenkins, J. L., Glick, M. & Davies, J. W. A 3D similarity method for scaffold hopping from known drugs or natural ligands to new chemotypes. J. Med. Chem.<\/i> 47<\/b>, 6144\u20136159 (2004).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Bailey, D. & Brown, D. High-throughput chemistry and structure-based design: survival of the smartest. Drug Discov. Today<\/i> 6<\/b>, 57\u201359 (2001).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Verdonk, M. L. & Hartshorn, M. J. Structure-guided fragment screening for lead discovery. Curr. Opin. Drug Discov. Devel.<\/i> 7<\/b>, 404\u2013410 (2004).
CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Villar, H. O., Yan, J. & Hansen, M. R. Using NMR for ligand discovery and optimization. Curr. Opin. Chem. Biol.<\/i> 8<\/b>, 387\u2013391 (2004).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Gillet, V. J., Khatib, W., Willett, P., Fleming, P. J. & Green, D. V. S. Combinatorial library design using a multiobjective genetic algorithm. J. Chem. Inf. Comput. Sci.<\/i> 42<\/b>, 375\u2013385 (2002).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Fonseca, C. M. & Fleming, P. J. in Genetic Algorithms: Proceedings of the Fifth International Conference<\/i> (ed. Forrest, S.) 416\u2013423 (Morgan Kaufmann: San Mateo, CA, 1993).
 Google Scholar<\/a>\u00a0
Handschuh, S., Wagener, M. & Gasteiger, J. Superposition of three-dimensional chemical structures allowing for conformational flexibility by a hybrid method. J. Chem. Inf. Comput. Sci.<\/i> 38<\/b>, 220\u2013232 (1998).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Agrafiotis, D. K. Multiobjective optimisation of combinatorial libraries. IBM J. Res. DeV.<\/i> 45<\/b>, 545\u2013566 (2001).
Article<\/a>\u00a0 CAS<\/a>\u00a0 Google Scholar<\/a>\u00a0
Wright, T., Gillet, V. J., Green, D. V. S. & Pickett, S. D. Optimizing the size and configuration of combinatorial libraries. J. Chem. Inf. Comput. Sci.<\/i> 43<\/b>, 381\u2013390 (2003).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Babine, R. E. et al. Design, synthesis and X-ray crystallographic studies of novel FKBB-12 ligands. Bioorg. Med. Chem. Lett.<\/i> 5<\/b>, 1719\u20131724 (1995).
Article<\/a>\u00a0 CAS<\/a>\u00a0 Google Scholar<\/a>\u00a0
Schindler, T. et al. Structural mechanism of STI-571 inhibition of Abelson tyrosine kinase. Science<\/i> 289<\/b>, 1938\u20131942 (2000).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Lewis, R. A. & Dean, P. M. Automated site-directed drug design: the concept of spacer skeletons for primary structure generation. Proc R Soc Lond B Biol Sci<\/i> B 236<\/b>, 125\u2013140 (1989). Pioneering theoretical outline to tackle the problem of automated drug design from first principles.<\/b>
PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
B\u00f6hm, H. -J. A novel computational tool for automated structure-based drug design. J. Mol. Recognit.<\/i> 6<\/b>, 131\u2013137 (1993). Concise overview of the early developments of the program LUDI.<\/b>
Article<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
B\u00f6hm, H. -J. The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure. J. Comput. Aided Mol. Des.<\/i> 8<\/b>, 243\u2013256 (1994).
Article<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
B\u00f6hm, H. -J. Prediction of binding constants of protein ligands: a fast method for the prioritization of hits obtained from de novo<\/i> design or 3D database search programs. J. Comput. Aided Mol. Des.<\/i> 12<\/b>, 309\u2013323 (1998).
Article<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Stultz, C. M. & Karplus, M. Dynamic ligand design and combinatorial optimization: designing inhibitors to endothiapepsin. Proteins<\/i> 40<\/b>, 258\u2013289 (2000).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Westhead, D. R. et al. PRO LIGAND: an approach to de novo<\/i> molecular design. 3. A genetic algorithm for structure refinement. J. Comput. Aided Mol. Des.<\/i> 9<\/b>, 139\u2013148 (1995).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Frenkel, D. et al. PRO LIGAND: an approach de novo<\/i> molecular design. 4. Application to the design of peptides. J. Comput. Aided Mol. Des.<\/i> 9<\/b>, 213\u2013225 (1995).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Clark, D. E. & Murray, C. W. PRO LIGAND: an approach to de novo<\/i> molecular design. 5. Tools for the Analysis of Generated Structures. J. Chem. Inf. Comput. Sci.<\/i> 35<\/b>, 914\u2013923 (1995).
Article<\/a>\u00a0 CAS<\/a>\u00a0 Google Scholar<\/a>\u00a0
Murray, C. W., Clark, D. E., Byrne, D. G. PRO LIGAND: an approach to de novo<\/i> molecular design. 6. Flexible fitting in the design of peptides. J. Comput. Aided Mol. Des.<\/i> 9<\/b>, 381\u2013395 (1995).
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 Google Scholar<\/a>\u00a0
Grzybowski, B. A. et al. Combinatorial computational method gives new picomolar ligands for a known enzyme. Proc. Natl Acad. Sci. USA<\/i> 99<\/b>, 1270\u20131273 (2002). Design of a picomolar human carbonic anhydrase II inhibitor, the highest-affinity inhibitor to date, with the program SMoG.<\/b>
Article<\/a>\u00a0 CAS<\/a>\u00a0 PubMed<\/a>\u00a0 PubMed Central<\/a>\u00a0 Google Scholar<\/a>\u00a0
Nachbar, R. B. Molecular evolution: a hierarchical representation for chemical topology and its automated manipulation. Proc. 3rd Ann. Genetic Programming Conf.<\/i> 246\u2013253 (Univ. of Wisconsin, Madison, Wisconsin 1998).
Wermuth, C. G., Gannelin, C. R., Lindberg, P. and Mitscher, L. A. Glossary of terms used in medicinal chemistry. Pure Appl. Chem.<\/i> 70<\/b>, 1129\u20131143 (1998).
Article<\/a>\u00a0 CAS<\/a>\u00a0 Google Scholar<\/a>\u00a0
Download references<\/use><\/svg><\/a>
H. Kubinyi is thanked for helpful discussion and kind support. This work was supported by the Beilstein-Institut zur F\u00f6rderung der Chemischen Wissenschaften, Frankfurt am Main. U.F. is thankful for a fellowship granted by Aventis Pharma Deutschland GmbH, a company of the Sanofi-Aventis group.
Johann Wolfgang Goethe-University, Institute of Organic Chemistry and Chemical Biology, Beilstein Endowed Chair for Cheminformatics, Marie-Curie-Str. 11 D-60439 Frankfurt am Main, Germany
Gisbert Schneider\u00a0&\u00a0Uli Fechner
You can also search for this author in PubMed<\/a>\u00a0<\/span>Google Scholar<\/a><\/span>
You can also search for this author in PubMed<\/a>\u00a0<\/span>Google Scholar<\/a><\/span>
Correspondence to Gisbert Schneider<\/a>.
The authors declare no competing financial interests.
Glossary of terms used in medicinal chemistry<\/a>
The design of bioactive compounds by incremental construction of a ligand model within a model of the receptor or enzyme active site, the structure of which is known from X-ray or NMR data106<\/a><\/sup>.
The identification of isofunctional structures with different backbone architectures.
All information that is related to the ligand\u2013receptor interaction \u2014 that is, the binding affinity of a ligand to the particular biological target.
A position in space that is not occupied by the receptor and in which a ligand atom favourably interacts with the receptor.
The ensemble of steric and electronic features that is necessary to ensure the optimal supramolecular interactions with a specific biological target structure and to trigger (or to block) its biological response106<\/a><\/sup>.
(QSAR). Mathematical relationships linking chemical structure and pharmacological activity in a quantitative manner for a series of compounds. Methods that can be used in QSAR include various regression and pattern-recognition techniques106<\/a><\/sup>.
Non-deterministic polynomial-time hard (NP-hard) refers to a class of decision problems of which current knowledge provides no way to obtain or derive a solution time that is less than exponential in problem size.
Application of probabilistic rules grounded on knowledge of a particular problem domain to obtain an algorithm that performs ‘reasonably well’ in many cases, but without proof that it is always fast.
Essential drug properties apart from the binding affinity to a biological target \u2014 for example, absorption, distribution, metabolism, excretion and toxicity properties, or binding selectivity.
Reprints and permissions<\/a>
Schneider, G., Fechner, U. Computer-based de novo<\/i> design of drug-like molecules. Nat Rev Drug Discov<\/i> 4<\/b>, 649\u2013663 (2005). https:\/\/doi.org\/10.1038\/nrd1799
Download citation<\/use><\/svg><\/a>
Issue Date: <\/span>

Provided by the Springer Nature SharedIt content-sharing initiative
Scientific Reports<\/i> (2024)
Nature Reviews Drug Discovery<\/i> (2024)
Journal of Cheminformatics<\/i> (2023)
Nature Computational Science<\/i> (2023)
Nature Communications<\/i> (2023)<\/p>\n

Advertisement
Nature Reviews Drug Discovery (Nat Rev Drug Discov<\/i>) <\/span> ISSN<\/abbr> 1474-1784<\/span> (online) <\/span> ISSN<\/abbr> 1474-1776<\/span> (print) <\/span>
© 2024 Springer Nature Limited
Sign up for the Nature Briefing<\/em> newsletter \u2014 what matters in science, free to your inbox daily.<\/p>\n

source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.Advertisement…<\/p>\n","protected":false},"author":1,"featured_media":13194,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31],"tags":[70],"class_list":["post-13193","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-design","tag-designer"],"yoast_head":"\nComputer-based de novo design of drug-like molecules - Nature - 4tuneagencia.digital<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Computer-based de novo design of drug-like molecules - Nature\" \/>\n<meta property=\"og:description\" content=\"Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.Advertisement...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/\" \/>\n<meta property=\"og:site_name\" content=\"4tuneagencia.digital\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-22T11:37:56+00:00\" \/>\n<meta name=\"author\" content=\"4tune\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"4tune\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"19 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/\"},\"author\":{\"name\":\"4tune\",\"@id\":\"https:\/\/4tuneagencia.digital\/blog\/#\/schema\/person\/7c40d2e8b9964c2390122613459c2100\"},\"headline\":\"Computer-based de novo design of drug-like molecules – Nature\",\"datePublished\":\"2024-03-22T11:37:56+00:00\",\"dateModified\":\"2024-03-22T11:37:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/\"},\"wordCount\":3871,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/4tuneagencia.digital\/blog\/#organization\"},\"image\":{\"@id\":\"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/4tuneagencia.digital\/blog\/wp-content\/uploads\/2024\/03\/wp-header-logo-300.png\",\"keywords\":[\"Designer\"],\"articleSection\":[\"Design\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/\",\"url\":\"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/\",\"name\":\"Computer-based de novo design of drug-like molecules - Nature - 4tuneagencia.digital\",\"isPartOf\":{\"@id\":\"https:\/\/4tuneagencia.digital\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/4tuneagencia.digital\/blog\/wp-content\/uploads\/2024\/03\/wp-header-logo-300.png\",\"datePublished\":\"2024-03-22T11:37:56+00:00\",\"dateModified\":\"2024-03-22T11:37:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/#primaryimage\",\"url\":\"https:\/\/4tuneagencia.digital\/blog\/wp-content\/uploads\/2024\/03\/wp-header-logo-300.png\",\"contentUrl\":\"https:\/\/4tuneagencia.digital\/blog\/wp-content\/uploads\/2024\/03\/wp-header-logo-300.png\",\"width\":442,\"height\":490},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/4tuneagencia.digital\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Computer-based de novo design of drug-like molecules – Nature\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/4tuneagencia.digital\/blog\/#website\",\"url\":\"https:\/\/4tuneagencia.digital\/blog\/\",\"name\":\"4tuneagencia.digital\",\"description\":\"Marketing e Web Designer \",\"publisher\":{\"@id\":\"https:\/\/4tuneagencia.digital\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/4tuneagencia.digital\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/4tuneagencia.digital\/blog\/#organization\",\"name\":\"4tuneagencia.digital\",\"url\":\"https:\/\/4tuneagencia.digital\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/4tuneagencia.digital\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/4tuneagencia.digital\/blog\/wp-content\/uploads\/2023\/09\/novo-logo-e1694954525541.png\",\"contentUrl\":\"https:\/\/4tuneagencia.digital\/blog\/wp-content\/uploads\/2023\/09\/novo-logo-e1694954525541.png\",\"width\":250,\"height\":250,\"caption\":\"4tuneagencia.digital\"},\"image\":{\"@id\":\"https:\/\/4tuneagencia.digital\/blog\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/4tuneagencia.digital\/blog\/#\/schema\/person\/7c40d2e8b9964c2390122613459c2100\",\"name\":\"4tune\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/4tuneagencia.digital\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e81e8ea0176022ee4555117aee5e3092bff2a7aaa930134f8023c7d4bc2f1495?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e81e8ea0176022ee4555117aee5e3092bff2a7aaa930134f8023c7d4bc2f1495?s=96&d=mm&r=g\",\"caption\":\"4tune\"},\"sameAs\":[\"http:\/\/4tuneagencia.digital\"],\"url\":\"https:\/\/4tuneagencia.digital\/blog\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Computer-based de novo design of drug-like molecules - Nature - 4tuneagencia.digital","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/","og_locale":"pt_BR","og_type":"article","og_title":"Computer-based de novo design of drug-like molecules - Nature","og_description":"Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.Advertisement...","og_url":"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/","og_site_name":"4tuneagencia.digital","article_published_time":"2024-03-22T11:37:56+00:00","author":"4tune","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"4tune","Est. tempo de leitura":"19 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/#article","isPartOf":{"@id":"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/"},"author":{"name":"4tune","@id":"https:\/\/4tuneagencia.digital\/blog\/#\/schema\/person\/7c40d2e8b9964c2390122613459c2100"},"headline":"Computer-based de novo design of drug-like molecules – Nature","datePublished":"2024-03-22T11:37:56+00:00","dateModified":"2024-03-22T11:37:56+00:00","mainEntityOfPage":{"@id":"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/"},"wordCount":3871,"commentCount":0,"publisher":{"@id":"https:\/\/4tuneagencia.digital\/blog\/#organization"},"image":{"@id":"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/#primaryimage"},"thumbnailUrl":"https:\/\/4tuneagencia.digital\/blog\/wp-content\/uploads\/2024\/03\/wp-header-logo-300.png","keywords":["Designer"],"articleSection":["Design"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/","url":"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/","name":"Computer-based de novo design of drug-like molecules - Nature - 4tuneagencia.digital","isPartOf":{"@id":"https:\/\/4tuneagencia.digital\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/#primaryimage"},"image":{"@id":"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/#primaryimage"},"thumbnailUrl":"https:\/\/4tuneagencia.digital\/blog\/wp-content\/uploads\/2024\/03\/wp-header-logo-300.png","datePublished":"2024-03-22T11:37:56+00:00","dateModified":"2024-03-22T11:37:56+00:00","breadcrumb":{"@id":"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/#primaryimage","url":"https:\/\/4tuneagencia.digital\/blog\/wp-content\/uploads\/2024\/03\/wp-header-logo-300.png","contentUrl":"https:\/\/4tuneagencia.digital\/blog\/wp-content\/uploads\/2024\/03\/wp-header-logo-300.png","width":442,"height":490},{"@type":"BreadcrumbList","@id":"https:\/\/4tuneagencia.digital\/blog\/computer-based-de-novo-design-of-drug-like-molecules-nature\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/4tuneagencia.digital\/blog\/"},{"@type":"ListItem","position":2,"name":"Computer-based de novo design of drug-like molecules – Nature"}]},{"@type":"WebSite","@id":"https:\/\/4tuneagencia.digital\/blog\/#website","url":"https:\/\/4tuneagencia.digital\/blog\/","name":"4tuneagencia.digital","description":"Marketing e Web Designer ","publisher":{"@id":"https:\/\/4tuneagencia.digital\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/4tuneagencia.digital\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/4tuneagencia.digital\/blog\/#organization","name":"4tuneagencia.digital","url":"https:\/\/4tuneagencia.digital\/blog\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/4tuneagencia.digital\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/4tuneagencia.digital\/blog\/wp-content\/uploads\/2023\/09\/novo-logo-e1694954525541.png","contentUrl":"https:\/\/4tuneagencia.digital\/blog\/wp-content\/uploads\/2023\/09\/novo-logo-e1694954525541.png","width":250,"height":250,"caption":"4tuneagencia.digital"},"image":{"@id":"https:\/\/4tuneagencia.digital\/blog\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/4tuneagencia.digital\/blog\/#\/schema\/person\/7c40d2e8b9964c2390122613459c2100","name":"4tune","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/4tuneagencia.digital\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e81e8ea0176022ee4555117aee5e3092bff2a7aaa930134f8023c7d4bc2f1495?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e81e8ea0176022ee4555117aee5e3092bff2a7aaa930134f8023c7d4bc2f1495?s=96&d=mm&r=g","caption":"4tune"},"sameAs":["http:\/\/4tuneagencia.digital"],"url":"https:\/\/4tuneagencia.digital\/blog\/author\/admin\/"}]}},"jetpack_featured_media_url":"https:\/\/4tuneagencia.digital\/blog\/wp-content\/uploads\/2024\/03\/wp-header-logo-300.png","_links":{"self":[{"href":"https:\/\/4tuneagencia.digital\/blog\/wp-json\/wp\/v2\/posts\/13193","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/4tuneagencia.digital\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/4tuneagencia.digital\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/4tuneagencia.digital\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/4tuneagencia.digital\/blog\/wp-json\/wp\/v2\/comments?post=13193"}],"version-history":[{"count":0,"href":"https:\/\/4tuneagencia.digital\/blog\/wp-json\/wp\/v2\/posts\/13193\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/4tuneagencia.digital\/blog\/wp-json\/wp\/v2\/media\/13194"}],"wp:attachment":[{"href":"https:\/\/4tuneagencia.digital\/blog\/wp-json\/wp\/v2\/media?parent=13193"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/4tuneagencia.digital\/blog\/wp-json\/wp\/v2\/categories?post=13193"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/4tuneagencia.digital\/blog\/wp-json\/wp\/v2\/tags?post=13193"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}